Aeglea BioTherapeutics In...

NASDAQ: AGLE · Real-Time Price · USD
12.01
0.75 (6.66%)
At close: Nov 27, 2023, 10:00 PM

Aeglea BioTherapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
PE Ratio
-34.74 -0.45 -4.75
PEG Ratio
n/a 0.71 0.14
PS Ratio
n/a 16.28 16.67
PB Ratio
13.95 0.75 3.72
P/FCF Ratio
-45.9 -0.47 -5.75
P/OCF Ratio
-45.9 -0.47 -5.81
OCF/S Ratio
n/a -34.41 -2.87
Debt / Equity Ratio
n/a 0.09 0.06
Quick Ratio
11.26 4.25 4.95
Current Ratio
11.26 4.25 4.91
Asset Turnover
n/a 0.03 0.17
Interest Coverage
n/a -101.29 n/a
Return on Equity
-0.4 -1.67 -0.78
Return on Assets
-0.34 -1.18 -0.6
Return on Invested Capital
-0.38 -1.48 -0.73
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
n/a 1.00 1.00
Net Profit Margin
n/a -35.99 -3.51
Pretax Profit Margin
n/a -36.05 -3.5
Operating Profit Margin
n/a -36.4 -3.5
FCF Margin
n/a n/a n/a
EBITDA Margin
n/a -36.4 -3.5